There are plenty stepping up to criticize industry super funds for their apparently overloaded weight to real assets that can’t be realised or readily valued in a period of market turmoil.
The S&P/ASX 200 (ASX: XJO) rose on Tuesday and is expected to rise again today following US markets.
Investors who are relying on bank stocks for dividends may need to look elsewhere as new measures mean they are likely to miss out on the equity income.
With investors desperately searching for strategies that have held up in the COVID-19 crash, the Cor Capital Fund is one that stands out, with a return for the March quarter of 0.47 per cent, net of fees – and a rise in April, at time of writing, of 2.75 per cent.
The Afterpay (ASX: APT) share price has jumped at the open after the buy now, pay later company gave a COVID-19 update. The share price is up 9 per cent in early trading.
Australian real estate investment trusts (REITs), often considered a defensive component in a portfolio, suffered the biggest fall of any asset class in March, according to Morningstar’s review of returns for the month.
Australian oil stocks including Woodside Petroleum Ltd (ASX: WPL), Santos Ltd (ASX: STO) and Oil Search Limited (ASX: OSH) will rebound.
In my opinion, RPMGlobal Holdings Ltd (ASX: RUL) is a hidden ASX small-cap share worthy of your attention.
I know it’s not very professional – nor profitable – to fall in the love with a company, even if the performance of the Xero Limited (ASX: XRO) share price still manages to bring a tear to this shareholder’s eye…
In the latest of our never sell stocks, is one of Australia’s true global leaders, CSL, or Commonwealth Serum Laboratories. The company was founded in 1916 and was actually part of the Federal Government at the time. CSL is a biopharmaceutical company that researches, develops, manufactures and markets products to treat and prevent human medical…